A city sees reduction in employee visits to the doctor’s office. How? EpiCor.
Posted Aug 16 2011 4:56pm
How do you measure improved immune function? Maybe by fewer sniffles and sneezes along with less itching and watery eyes during allergy season. Maybe by less coughing and wheezing along with reduced fever and body aches during winter crud season.
Here’s another measure, especially if you are an employer that provides group health insurance to your employees: reduction in the number of doctor office visits by employees. Specifically visits for cold, flu and upper respiratory tract infections (URTI). That decline in employee doctor visits was the overriding result of a 6-month project undertaken by the City of Ankeny in Iowa.
Ankeny is one of the fastest growing suburban cities in the country and the fastest growing city in Iowa. It’s city administration embraces new approaches and strategies to city management, including employee wellness and health. Last October, the city partnered with Embria Health Sciences, headquartered in Ankeny, to initiate an informal trial of Embria’s EpiCor immune balancing nutritional supplement. Eighty employees and 18 of their family members volunteered to take a 500-mg daily EpiCor supplement for 6 months. During that time, the employees were asked to keep records of the any illness symptoms they encountered, and to log any doctor’s office visits for cold, flu or URTI type symptoms.
The results: doctor’s office visits declined by 28 percent over the prior year.
This, of course, is not a clinical trial or even a controlled pilot study. It was simply designed as an observational project to take a broad look at employee health and wellness experiences while taking EpiCor. The results, however, do closely align with results of other more structured, human clinical trials involving EpiCor, using placebo control and gaining publication in peer-reviewed journals.
How do you measure improved immune function? Maybe by fewer sniffles and sneezes along with less itching and watery eyes during allergy
season. Maybe by less coughing and wheezing along with reduced fever and body aches during winter crud season.
Here’s another measure, especially if you are an employer that provides group health insurance to your employees: reduction in the number of doctor office visits by employees. Specifically visits for cold, flu and upper respiratory tract infections (URTI). That decline in employee doctor visits was the overriding result of a 6-month project undertaken by the City of Ankeny in Iowa.
Ankeny is one of the fastest growing suburban cities in the country and the fastest growing city in Iowa. It’s city administration embraces new approaches and strategies to city management, including employee wellness and health. Last October, the city partnered with Embria Health Sciences, headquartered in Ankeny, to initiate an informal trial of Embria’s EpiCor immune balancing nutritional supplement. Eighty employees and 18 of their family members volunteered to take a 500-mg daily EpiCor supplement for 6 months. During that time, the employees were asked to keep records of the any illness symptoms they encountered, and to log any doctor’s office visits for cold, flu or URTI type symptoms.
The results: doctor’s office visits declined by 28 percent over the prior year.
This, of course, is not a clinical trial or even a controlled pilot study. It was simply designed as an observational project to take a broad look at employee health and wellness experiences while taking EpiCor. The results, however, do closely align with results of other more structured, human clinical trials involving EpiCor, using placebo control and gaining publication in peer-reviewed journals.